0000874015-11-000035.txt : 20111222 0000874015-11-000035.hdr.sgml : 20111222 20111222172043 ACCESSION NUMBER: 0000874015-11-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111221 FILED AS OF DATE: 20111222 DATE AS OF CHANGE: 20111222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 111278286 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2011-12-21 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073385 PARSHALL B LYNNE C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 Director, COO Common Stock 2011-12-21 2011-12-21 4 M 0 2363 5.80 A 4348 D Common Stock 2011-12-21 2011-12-21 4 S 0 2363 6.92 D 1985 D Common Stock 2011-12-21 2011-12-21 4 M 0 2200 5.80 A 2200 I By daughter Common Stock 2011-12-21 2011-12-21 4 S 0 2200 6.92 D 0 I By daughter Common Stock 2011-12-21 2011-12-21 4 M 0 2200 5.80 A 2200 I By daughter Common Stock 2011-12-21 2011-12-21 4 S 0 2200 6.92 D 0 I By daughter Employee Stock Option (right to buy) 5.80 2011-12-21 2011-12-21 4 M 0 2363 0 D 2009-01-03 2012-01-02 Common Stock 2363 0 D Employee Stock Option (right to buy) 5.80 2011-12-21 2011-12-21 4 M 0 2200 0 D 2009-01-03 2012-01-02 Common Stock 2200 0 I By daughter Employee Stock Option (right to buy) 5.80 2011-12-21 2011-12-21 4 M 0 2200 0 D 2009-01-03 2012-01-02 Common Stock 2200 0 I By daughter Acquired as a result of exercising a stock option that was scheduled to expire on 1/2/12. The purchase and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/21/11. /s/B. Lynne Parshall 2011-12-22